JACC Publishes MARISA Trial Results, Including Anti-Ischemic and Long-Term Survival Data
April 20 2004 - 6:00PM
PR Newswire (US)
JACC Publishes MARISA Trial Results, Including Anti-Ischemic and
Long-Term Survival Data PALO ALTO, Calif., April 20
/PRNewswire-FirstCall/ -- Data from the Monotherapy Assessment of
Ranolazine In Stable Angina (MARISA) trial showing that Ranexa(TM)
(ranolazine) produced statistically significant (p
CV Therapeutics (NASDAQ:CVTX)
Historical Stock Chart
From Jun 2024 to Jul 2024
CV Therapeutics (NASDAQ:CVTX)
Historical Stock Chart
From Jul 2023 to Jul 2024